CORNEIL 5
[pdf-embedder url="http://davipharm.info/wp-content/uploads/Toa-CORNEIL-TT-01_cv-5393e.2024.pdf"]CORNEIL-2,5
[pdf-embedder url="http://davipharm.info/wp-content/uploads/CORNEIL-25-0049.T2.pdf"]DASARAB
[pdf-embedder url="http://davipharm.info/wp-content/uploads/DASARAB_06-DOT-162-2.pdf"]TEGRUCIL-4
Heart disease causing embolism: Prevention of thromboembolism complications caused by atrial fibrillation, mitral valve disease, artificial valve. Myocardial infarction: Prevention of thromboembolism complications in myocardial…RAVENELL-62.5
Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and symptoms in patients with WHO functional class III. Efficacy has been shown in: •…RAVENELL-125
Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and symptoms in patients with WHO functional class III. Efficacy has been shown in: •…GON SA EZETI-10
Primary Hypercholesterolaemia: Ezetimibe co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial…GON SA ATZETI
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due…ESSEIL-5
Cilnidipin is indicated for the treatment of hypertension. This is only the preview. Please check here for the full indication.VASLOR-20
Hypercholesterolaemia Atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-C), LDL-cholesterol (LDL-C), apolipoprotein B, and triglycerides in adults, adolescents…VASLOR-10
Atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-C), LDL-cholesterol (LDL-C), apolipoprotein B, and triglycerides in patients with primary…











